Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121167163 | 12116716 | 3 | F | 20160913 | 20160225 | 20160915 | EXP | CA-009507513-1602CAN010290 | MERCK | 46.00 | YR | F | Y | 72.00000 | KG | 20160915 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121167163 | 12116716 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | UNK | U | 21995 | FILM-COATED TABLET | ||||||||
121167163 | 12116716 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, 1 EVERY 4 WEEKS | U | 0 | 600 | MG | |||||||
121167163 | 12116716 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, 1 EVERY 4 WEEKS | U | 0 | 680 | MG | |||||||
121167163 | 12116716 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
121167163 | 12116716 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, 1 EVERY 4 WEEKS | U | 0 | 600 | MG | |||||||
121167163 | 12116716 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 616 MG, 1 EVERY 4 WEEKS | U | 0 | 616 | MG | |||||||
121167163 | 12116716 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 672 MG, 1 EVERY 4 WEEKS | U | 0 | 672 | MG | |||||||
121167163 | 12116716 | 8 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | U | 0 | |||||||||
121167163 | 12116716 | 9 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | |||||||
121167163 | 12116716 | 10 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 5 MG, BID | U | 0 | 5 | MG | BID | ||||||
121167163 | 12116716 | 11 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
121167163 | 12116716 | 12 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
121167163 | 12116716 | 13 | C | RANITIDINE. | RANITIDINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121167163 | 12116716 | 1 | Diabetes mellitus |
121167163 | 12116716 | 2 | Rheumatoid arthritis |
121167163 | 12116716 | 8 | Diabetes mellitus |
121167163 | 12116716 | 9 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121167163 | 12116716 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121167163 | 12116716 | Abdominal pain upper | |
121167163 | 12116716 | Blood pressure systolic decreased | |
121167163 | 12116716 | Bronchitis | |
121167163 | 12116716 | Cough | |
121167163 | 12116716 | Diarrhoea | |
121167163 | 12116716 | Dizziness | |
121167163 | 12116716 | Fatigue | |
121167163 | 12116716 | Gastrointestinal disorder | |
121167163 | 12116716 | Headache | |
121167163 | 12116716 | Lower respiratory tract infection | |
121167163 | 12116716 | Nasal congestion | |
121167163 | 12116716 | Nasopharyngitis | |
121167163 | 12116716 | Oropharyngeal pain | |
121167163 | 12116716 | Respiratory tract congestion | |
121167163 | 12116716 | Sinus congestion | |
121167163 | 12116716 | Swelling face | |
121167163 | 12116716 | Tooth disorder | |
121167163 | 12116716 | Type 2 diabetes mellitus | |
121167163 | 12116716 | Vomiting | |
121167163 | 12116716 | Weight decreased | |
121167163 | 12116716 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |